Characterization of a monoclonal antibody, D73H, that maps to a highly conserved region on fibrinogen Bβ chain

Thrombosis and Haemostasis

Volumn 84, Issue 1, 2000, Pages 43-48

  Rybarczyk, B J ^a,b   Pereira, M ^a,b   Simpson Haidaris, P J ^a,b,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Department of Pathology ^*  (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Crystal structure; Cyanogen bromide; Epitope mapping; In silico analysis; Plasmin

Indexed keywords

EPITOPE; FIBRINOGEN; MONOCLONAL ANTIBODY; PLASMIN;

AMINO ACID SEQUENCE; ARTICLE; CATTLE; CRYSTAL STRUCTURE; GUINEA PIG; HUMAN; HYDROPHILICITY; IMMUNOGENICITY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; SPECIES; WESTERN BLOTTING;

EID: 0033919323     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613965     Document Type: Article

References (38)

1. Odrljin TM, Shainoff JR, Lawrence SO, Simpson-Haidaris PJ. Thrombin cleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin β chain. Blood 1996; 88: 2050-61.
2. Doolittle RF, Goldhaum DM, Doolittle LR. Designation of sequences involved in the "coiled-coil" interdominal connections in fibrinogen: constructions of an atomic scale model. J Mol Biol 1978; 120: 311-25.
3. Doolittle RF. A detailed consideration of a principal domain of vertebrate fibrinogen and its relatives. Protein Sci 1992; 1: 1563-77.
4. Hantgan RR, Simpson-Haidaris PJ, Francis CW, Marder VJ. Fibrinogen structure and physiology. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Haemostasis and Thrombosis: Basic Principles and Clinical Practice. 4th ed. Philadelphia: JB Lippincott Company, in press.
5. 2-terminal region of fibrin. Mol Immunol 1984; 21: 89-94.
6. Hui KY, Haber E, Matsueda GR. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human but not fibrinogen. Science 1983; 222: 1129-32.
7. Fair DS, Edginglon TS, Plow EF. Immunochemical mapping of the conformation of human fibrinogen. The γ95-265 segment in inaccessible to antibody in native fibrinogen but progressively exposed by plasmic cleavage. J Biol Chem 1981; 256: 8018-23.
8. 2-terminal fragments derived from fibrinogen and fibrin. Mol Immunol 1983; 20: 1191-200.
9. Odrljin TM, Rybarczyk BJ, Francis CW, Lawrence SO, Hamaguchi M, Simpson-Haidaris PJ. Calcium modulates plasmin cleavage of the fibrinogen D fragment γ chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the γ chain. Biochim Biophys Acta 1996; 1298: 69-77.
10. Haidaris PJ, Francis CW, Sporn LA, Arvan DS, Collichio FA, Marder VJ. Megakaryocyte and hepatocyte origins of human fibrinogen biosynthesis exhibit hepatocyte-specific expression of γ chain-variant polypeptides. Blood 1989; 74: 743-50.
11. Koppert PW, Koopman J, Haverkate F, Nieuwenhuizen W. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising Bβ54-118) in degradation products of fibrin and of fibrinogen. Blood 1986; 68: 437-41.
12. Haidaris PJ, Peerschke EI, Marder VJ, Francis CW. The C-terminal sequences of the γ57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin. Blood 1989; 74: 2437-44.
13. Harlow E, Lane D. Antibodies, a laboratory manual Cold Spring Harbor: CSHL Press, 1988.
14. Odrljin TM, Francis CW, Sporn LA, Bunce LA, Marder VJ, Simpson-Haidaris PJ. Heparin-binding domain of fibrin mediates its binding to endothelial cells. Arteriosclerosis, Thrombosis Vascular Biol 1996; 16: 1544-51.
15. Lawrence SO, Wright TW, Francis CW, Fay PJ, Haidaris PJ. Purification and functional characterization of homodimeric γB-γ B fibrinogen from rat plasma. Blood 1993; 82: 2406-13.
16. Simpson-Haidaris PJ, Wright TW, Earnest BJ, Hui Z, Neroni LA, Courtney MA. Cloning and characterisation of a lung-specific cDNA corresponding to the γ chain of hepatic fibrinogen. Gene 1995; 167: 273-8.
17. Cleveland DW, Fischer SG, Kirschner MW, Laemmli UK. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem 1977; 252: 1102-6.
18. Everse SJ, Spraggon G, Veerapandian L, Riley M, Doolitlle RF. Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry 1998; 37: 8637-42.
19. Cierniewski CS, Budzynski AZ. Involvement of the a chain in fibrin clot formation. Effect of monoclonal antibodies. Biochemistry 1992; 31: 4248-53.
20. Kini RM, Evans HJ. Prediction of potential protein-protein interaction sites from amino acid sequence. Identification of a fibrin polymerization site. FEBS Lett 1996; 385: 81-6.
21. Kini RM, Evans HJ. A hypothetical structural role for proline residues in the flanking segments of protein-protein interaction sites. Biochem Biophys Res Commun 1995; 212: 1115-24.
22. Chang MC, Jeng JH, Cheong TC, Huang TF. The morphologic change of endothelial cells by ancrod-generated fibrin is triggered by αvβ3 integrin binding and the subsequent activation of a G-protein coupled phospholipase C. Biochem Biophys Acta 1995; 1269: 115-21.
23. Chang MC, Wang BR, Huang TF. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides. Thromb Haemost 1995; 74: 764-9.
24. Altieri DC, Plescia J, Plow EF. The structural motif glycine 190-valine 202 of the fibrinogen γ chain interacts with CD11b/CD18 integrin (αMβ2, Mac-1) and promotes leukocyte adhesion. J Biol Chem 1993; 268: 1847-53.
25. Altieri DC, Duperray A, Plescia J, Thornton GB, Languino LR. Structural recognition of a novel fibrinogen γ chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 1995; 270: 696-9.
26. Cheresh DA, Berliner SA, Vicente V, Ruggeri ZM. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989; 58: 945-53.
27. Rudchenko S, Trakht I, Sobel JH. Comparative structural and functional features of the human fibrinogen α C domain and the isolated αC fragment. Characterization using monoclonal antibodies to defined COOH-terminal Aα chain regions. J Biol Chem 1996; 271: 2523-30.
28. Hawiger J. Adhesive interactions of platelets and their blockade. Ann N Y Acad Sci 1991; 614: 270-8.
29. Francis CW, Bunce LA, Sporn LA. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the β chain. Blood Cells 1993; 19: 291-306.
30. Bunce LA, Sporn LA, Francis CW. Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the β chain. J Clin Invest 1992; 89: 842-50.
31. Hamaguchi M, Bunce LA, Sporn LA, Francis CW. Spreading of platelets on fibrin is mediated by the amino terminus of the β chain including peptide β15-42. Blood 1993; 81: 2348-56.
32. Sporn LA, Bunce LA, Francis CW. Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood 1995; 86: 1802-10.
33. Francis CW, Marder VJ. A molecular model of plasmic degradation of crosslinked fibrin. Sem Thromb Hemost 1982; 8: 25-35.
34. Budzynski AZ, Marder VJ. Degradation pathway of fibrinogen by plasmin. Thromb Haemost 1977; 38: 793-800.
35. Bacon-Baguley T, Ogilvie ML, Gartner TK, Walz DA. Thrombospondin binding to specific sequences within the Aα-and Bβ-chains of fibrinogen. J Biol Chem 1990; 265: 2317-23.
36. Tran H, Tanaka A, Litvinovich SV, Medved LV, Haudenschild CC, Argraves WS. The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis. J Biol Chem 1995; 270: 19458-64.
37. Godyna S, Diaz-Ricart M. Argraves WS. Fibulin-1 mediates platelet adhesion via a bridge of fibrinogen. Blood 1996; 88: 2569-77.
38. Guadiz G, Sporn LA, Simpson-Haidaris PJ. Thrombin cleavage-independent deposition of fibrinogen in extracellular matrices. Blood 1997; 90: 2644-53.